Post Profile

Lab tests show molecule appears to spur cell death in tumors, inflammation

(Duke University Medical Center) A drug-like molecule developed by Duke Health researchers appears to intercede in an inflammatory response that is at the center of a variety of diseases, including some cancers, rheumatoid arthritis and Crohn's disease.
read more


Related Posts

Finding A Potential New Target for Treating Rheumatoid Arthritis

Health : Newswise Medical News

By enhancing the activity of immune cells that protect against runaway inflammation, researchers at NYU Langone Medical Center may have found a novel therapy for rheumatoid arthritis and other autoimmune diseases. In a new study pub...

Hibernating control cells or why inflammations become chronic

Health : EurekAlert: Health

(University of Erlangen-Nuremberg) Rheumatoid arthritis is the most common autoimmune disease of the joints. It causes a chronic inflammatory response, with the body's own immune cells attacking the joint, including the cartilage an...

Medical News Today: Rheumatoid arthritis: Birth control pill tied to reduced risk

Health : Medical News Today

A large Swedish study has found that women who had used contraceptive pills had less risk of developing rheumatoid arthritis than women who had not.

GIST tumors linked to NF1 mutations, genetic testing needed

Diseases & Conditions / Cancer : EurekAlert: Cancer

(University of California - San Diego) Researchers at UC San Diego Moores Cancer Center, with colleagues from Memorial Sloan Kettering Cancer Center and Fox Chase Cancer Center, have determined that a specific region of the small bo...

Improved Understanding Of The Very Early Stages In The Development Of Inflammatory Diseases Such As Atherosclerosis And Rheumatoid Arthritis

Health : Medical News Today

Scientists at the University of East Anglia (UEA) have discovered a 'constant cloud' of potent inflammatory molecules surrounding the cells responsible for diseases such as thickening of the arteries and rheumatoid arthritis. Publis...


Copyright © 2016 Regator, LLC